KCNH2 and acute lymphoblastic leukemia: Indeed, E4031, a hERG1 inhibitor, promoted B-ALL cell death and worked synergistically with doxorubicin, methotrexate and prednisolone treatments in cocultures of primary B-ALL cells or cell lines with BM-MSCs [57].